UpHealth, Inc.
UPH · NYSE
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Revenue | $33 | $38 | $42 | $40 |
| % Growth | -13.6% | -10.3% | 4.1% | – |
| Cost of Goods Sold | $15 | $18 | $19 | $22 |
| Gross Profit | $18 | $20 | $23 | $18 |
| % Margin | 53.9% | 52.8% | 53.8% | 45% |
| R&D Expenses | $2 | $1 | $1 | $2 |
| G&A Expenses | $9 | $14 | $12 | $14 |
| SG&A Expenses | $12 | $16 | $17 | $18 |
| Sales & Mktg Exp. | $3 | $2 | $5 | $4 |
| Other Operating Expenses | $62 | $0 | $2 | $3 |
| Operating Expenses | $16 | $19 | $20 | $23 |
| Operating Income | -$73 | -$11 | $3 | -$4 |
| % Margin | -222.7% | -28.4% | 7.5% | -11.1% |
| Other Income/Exp. Net | $53 | -$7 | -$7 | -$5 |
| Pre-Tax Income | -$20 | -$18 | -$8 | -$19 |
| Tax Expense | $0 | $1 | $0 | $8 |
| Net Income | -$21 | -$19 | -$8 | -$27 |
| % Margin | -63% | -50.6% | -19.2% | -67.1% |
| EPS | -1.12 | -1.05 | -0.51 | -1.81 |
| % Growth | -6.7% | -105.9% | 71.8% | – |
| EPS Diluted | -1.12 | -1.05 | -0.51 | -1.81 |
| Weighted Avg Shares Out | 18 | 18 | 16 | 15 |
| Weighted Avg Shares Out Dil | 18 | 18 | 16 | 15 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $7 | $0 |
| Interest Expense | $7 | $7 | $7 | $6 |
| Depreciation & Amortization | $4 | $4 | $3 | $5 |
| EBITDA | -$9 | -$7 | $6 | $1 |
| % Margin | -28.9% | -18.5% | 14.6% | 1.4% |